Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10166181 | VERITY | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(6 years from now) |
Market Authorisation Date: 10 March, 2010
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR
4
European Union
3
United States
2
RS
2
Poland
2
Lithuania
2
Spain
2
Cyprus
2
Slovenia
2
IB
2
Hungary
2
Portugal
2
Croatia
2
Denmark
1
Hong Kong
1
Morocco
1
Korea, Republic of
1
Brazil
1
AP
1
Australia
1
Malaysia
1
Ukraine
1
Israel
1
Mexico
1
Japan
1
Tunisia
1
South Africa
1
Colombia
1
China
1
EA
1
ME
1
New Zealand
1
Canada
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10166181 | ARBOR PHARMS LLC | Slow release pharmaceutical composition made of microgranules |
Jun, 2029
(6 years from now) |
Exclusivity | Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity (ODE) | Jun 29, 2024 |
Market Authorisation Date: 29 June, 2017
Treatment: NA
Dosage: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
4
European Union
3
United States
2
RS
2
Poland
2
Lithuania
2
Spain
2
Cyprus
2
Slovenia
2
IB
2
Hungary
2
Portugal
2
Croatia
2
Denmark
1
Hong Kong
1
Morocco
1
Korea, Republic of
1
Brazil
1
AP
1
Australia
1
Malaysia
1
Ukraine
1
Israel
1
Mexico
1
Japan
1
Tunisia
1
South Africa
1
Colombia
1
China
1
EA
1
ME
1
New Zealand
1
Canada
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic